↓ Skip to main content

Blood pressure control in type 2 diabetic patients

Overview of attention for article published in Cardiovascular Diabetology, January 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (75th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter
10 X users

Citations

dimensions_citation
77 Dimensions

Readers on

mendeley
251 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Blood pressure control in type 2 diabetic patients
Published in
Cardiovascular Diabetology, January 2017
DOI 10.1186/s12933-016-0485-3
Pubmed ID
Authors

Alon Grossman, Ehud Grossman

Abstract

Diabetes mellitus (DM) and essential hypertension are common conditions that are frequently present together. Both are considered risk factors for cardiovascular disease and microvascular complications and therefore treatment of both conditions is essential. Many papers were published on blood pressure (BP) targets in diabetic patients, including several works published in the last 2 years. As a result, guidelines differ in their recommendations on BP targets in diabetic patients. The method by which to control hypertension, whether pharmacological or non-pharmacological, is also a matter of debate and has been extensively studied in the literature. In recent years, new medications were introduced for the treatment of DM, some of which also affect BP and the clinician treating hypertensive and diabetic patients should be familiar with these medications and their effect on BP. In this manuscript, we discuss the evidence supporting different BP targets in diabetics and review the various guidelines on this topic. In addition, we discuss the various options available for the treatment of hypertension in diabetics and the recommendations for a specific treatment over the other. Finally we briefly discuss the new diabetic drug classes and their influence on BP.

X Demographics

X Demographics

The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 251 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
India 1 <1%
Unknown 249 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 40 16%
Student > Bachelor 34 14%
Researcher 21 8%
Student > Doctoral Student 17 7%
Student > Postgraduate 16 6%
Other 34 14%
Unknown 89 35%
Readers by discipline Count As %
Medicine and Dentistry 54 22%
Pharmacology, Toxicology and Pharmaceutical Science 27 11%
Nursing and Health Professions 20 8%
Biochemistry, Genetics and Molecular Biology 15 6%
Sports and Recreations 6 2%
Other 31 12%
Unknown 98 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 February 2019.
All research outputs
#5,712,890
of 23,802,430 outputs
Outputs from Cardiovascular Diabetology
#384
of 1,451 outputs
Outputs of similar age
#101,931
of 424,375 outputs
Outputs of similar age from Cardiovascular Diabetology
#9
of 20 outputs
Altmetric has tracked 23,802,430 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,451 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.4. This one has gotten more attention than average, scoring higher than 73% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 424,375 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.